The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.
The evolution of commercial drug delivery technologies
Abstract
Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ultimate goal of the development of smart nanoparticles is that the payloads can better serve patients: enhance curative effect, reduce toxicity and prolong survival.276”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [276]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Research works printed but not linked: 2
- Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
- DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).
Cited by
Sorted by citations
Items 401–500 of 1,000
Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles
Fernandes, S., Cassani, M., Cavalieri, F., Forte, G., & Caruso, F. (2023) · Advanced Science · doi:10.1002/advs.202305769 · Cited by 20
Sharma, A. K., Singh, M., Sharma, V., Vashishth, A., Raj, M., Upadhyay, S. K., Singh, S., Ramniwas, S., Dhama, K., Sharma, A. K., et al. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113745 · Cited by 20
Zhang, Y., Jiang, L., Huang, S., Lian, C., Liang, H., Xing, Y., Liu, J., Tian, X., Liu, Z., Wang, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202307754 · Cited by 19
Vieira, C. P., Lelis, C. A., Ochioni, A. C., Rosário, D. K. A., Rosario, I. L. D. S., Vieira, Í. R. S., Carvalho, A. P. A., Janeiro, J. M., da Costa, M. P., Lima, F. R. S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116884 · Cited by 22
Nanoparticle-based drug delivery systems: An updated strategy for treating fungal keratitis
Guo, Y. X., & He, Y. X. (2024) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2024.100794 · Cited by 20
Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
Reddiar, S. B., Xie, Y., Abdallah, M., Han, S., Hu, L., Feeney, O. M., Gracia, G., Anshabo, A., Lu, Z., Farooq, M. A., et al. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001159 · Cited by 20
Wang, H., Liu, X., Yan, X., Du, Y., Pu, F., Ren, J., & Qu, X. (2024) · Chemical Science · doi:10.1039/d4sc05280c · Cited by 19
Srivastava, A., Kumar, M., & Ahmed, M. Z. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126114 · Cited by 19
Xu, D., Ju, J., Chen, W., Miao, J., Chen, S., Wang, J., Xu, L., Ge, G., & Deng, H. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123885 · Cited by 19
Controlled Release of Microorganisms from Engineered Living Materials
Kalairaj, M. S., George, I., George, S. M., Farfán, S. E., Lee, Y., Rivera‐Tarazona, L. K., Wang, S., Abdelrahman, M. K., Tasmim, S., Dana, A., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11155 · Cited by 19
“1,2,6,7 Although fundamental relationships that govern the release kinetics of small molecules and macromolecules from synthetic materials have been developed, 1,2 the governing mechanisms that control the release of microorganisms in a controlled and sustained manner have not been established.”
Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors
Wang, Q., Chen, Z., Zhang, G., Yang, J., Hu, R., Yao, T., Zeng, C., Zhang, S., Jiang, W., Zhu, S., et al. (2026) · Science · doi:10.1126/science.adu7686 · Cited by 19
Alrumaihi, F., Khan, M. A., Babiker, A. Y., Alsaweed, M., Azam, F., Allemailem, K. S., Almatroudi, A., Ahamad, S. R., Alsuhaymi, N., Alsugoor, M. H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020236 · Cited by 19
Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases
Solomon, M. A., Loeck, M., Silva-Abreu, M., Moscoso, R., Bautista, R., Vigo, M., & Muro, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.022 · Cited by 18
Han, D., Li, C., Araimdeh, S., Sree, V. D., Rahimi, E., Tepole, A. B., & Ardekani, A. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.045 · Cited by 19
Wei, X., Yang, D., Zheng, X., Cai, J., Wang, L., Zhao, C., Wei, X., Jiang, M., Sun, H., Zhou, L., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm00261f · Cited by 20
Lubricated Interfaces Enabling Simultaneous Pulsatile and Continuous Chemical Release Modes
Borbora, A., Xu, Y., Dey, S., Wang, X., Yao, Y., Mandal, B. B., Wang, X., & Manna, U. (2023) · Advanced Materials · doi:10.1002/adma.202302264 · Cited by 20
Recent Advances in Engineering Carriers for siRNA Delivery
Yang, C., Lin, Z., Zhang, X., Xu, Z., Xu, G., Wang, Y., Tsai, T., Cheng, P., Law, W., Yong, K., et al. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300362 · Cited by 21
Chen, L., Jiang, C., Xu, Q., Jin, J., Sigen, A., Wang, X., Li, X., Hu, Y., Sun, H., Lu, X., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.016 · Cited by 19
Yu, Y., Zuo, S., Song, J., Li, L., Liu, T., Guo, J., Li, Y., Wang, D., Lu, Q., Wang, H., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6533-5 · Cited by 19
Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration
Desai, N., Pande, S., Vora, L. K., & Kommineni, N. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00613 · Cited by 18
“161 Chemical composition analysis, conducted through in-line Fourier-transform infrared spectroscopy, can help ensure the identity and purity of the materials used.”
MethodStepanova, M., Добродумов, А. В., Averianov, I. V., Gofman, I. V., Nashchekina, J., Guryanov, I., Klyukin, I. N., Zhdanov, A. P., Korzhikova‐Vlakh, E., & Zhizhin, K. Y. (2022) · Polymers · doi:10.3390/polym14183864 · Cited by 18
“Unlike traditional medicinal therapy, targeted drug delivery provides more efficient treatment and does not affect other organs and healthy cells [1,2].”
BackgroundProgrammable self-regulated molecular buffers for precise sustained drug delivery
Desrosiers, A., Derbali, R. M., Hassine, S., Berdugo, J., Long, V., Lauzon, D., Guire, V. D., Fiset, C., DesGroseillers, L., Chain, J. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33491-7 · Cited by 18
Dahiya, M., Awasthi, R., Dua, K., & Dureja, H. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104044 · Cited by 18
Carbon Nanotube Hybrid Materials: Efficient and Pertinent Platforms for Antifungal Drug Delivery
Chandra, D. K., Reis, R. L., Kundu, S. C., Kumar, A., & Mahapatra, C. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202301044 · Cited by 19
Advanced optical imaging for the rational design of nanomedicines
Ortiz‐Perez, A., Zhang, M., Fitzpatrick, L. W., Izquierdo-Lozano, C., & Albertazzi, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115138 · Cited by 18
Wei, T., Zhao, R., Fang, L., Li, Z., Yang, M. W., Zhan, Z., Cheang, U. K., & Hu, C. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202311908 · Cited by 18
Li, W.-Z., Wang, X., Liu, L., Xiao, J., Wang, X., Ye, Y., Wang, Z.-X., Zhu, M., Sun, Y., Stang, P. J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2318391121 · Cited by 18
“Currently, the traditional routes of drug administration are oral and parenteral, but these methods have clear disadvantages, such as gastrointestinal irritation and first - pass inactivation, which cannot resolve side effects (13).”
Recent progress in chitosan-based nanofibers as potential drug carriers in cancer therapy
Sen, O., Jana, S., Nandi, G., & Manna, S. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2344618 · Cited by 18
“Over the years, remarkable efforts are being made to vary the dose and forms of drug delivery systems, alongside the routes of drug administration [1,2] .”
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery
Ma, Y., Tiwade, P. B., VanKeulen‐Miller, R., Narasipura, E. A., & Fenton, O. S. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c01235 · Cited by 19
Drug delivery systems for tissue engineering: exploring novel strategies for enhanced regeneration
de Oliveira, J. L., da Silva, M. E. X., Hotza, D., Sayer, C., & Immich, A. P. S. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06074-4 · Cited by 18
“These polymers exhibit good biocompatibility and suitable degradability, further expanding their applications in the field [54–58].”
Zhang, R., Tan, W., & Ji, D. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102399 · Cited by 18
Rota, G. F., Amor, C., Clainche, S. L., & Rosti, M. (2023) · Physical Review Fluids · doi:10.1103/physrevfluids.9.l122602 · Cited by 15
Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study
Melo, R. L. F., Dari, D. N., Aires, F. I. D. S., Neto, F. S., Freire, T. M., Fernandes, B. C. C., Fechine, P. B. A., Soares, J. M., & dos Santos, J. C. S. (2025) · ACS Omega · doi:10.1021/acsomega.4c08669 · Cited by 18
Kopač, T., Krajnc, M., & Ručigaj, A. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112677 · Cited by 18
“Controlled drug delivery at the target site has been the subject of research for decades [1], and it is still being developed with the aim of achieving higher treatment efficiency and lower patient burden [2].”
Advanced Drug Delivery Systems
Prajapati, B. G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100967 · Cited by 18
Pham, K., Khanal, S., Bohara, G., Rimal, N., Song, S.-H., Nguyen, T. T. K., Hong, I., Cho, J., Kang, J.-S., Lee, S., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103457 · Cited by 18
Recapitulating the potential contribution of protein S-palmitoylation in cancer
Chaturvedi, S., & Sonawane, A. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10217-3 · Cited by 17
Zhou, Z., Bai, X., Zhou, Z.-Y., Lin, Z., Liao, B., Gong, F., Wang, M.-Q., Chen, X.-B., Liu, Y., Chen, H., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113728 · Cited by 17
3D printed metamaterials: properties, fabrication, and drug delivery applications
Singh, H., Tuffaha, M., Tripathi, S., Bal‐Öztürk, A., Dave, H., Dhanka, M., Avcı, H., Nanda, H. S., & Hassan, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115636 · Cited by 17
High‐Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline
Lam, L., Watson, S. L., Ramaswamy, Y., & Singh, G. (2025) · Advanced Science · doi:10.1002/advs.202511551 · Cited by 22
Oral Thin-films from Design to Delivery: A Pharmaceutical Viewpoint
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac132.177 · Cited by 17
“As opposed to a normal tablet, fast-dissolve tablets are made with water-soluble excipients or super-disintegrant or effervescent components to enable rapid water penetration into the interior of the tablet [12].”
BackgroundSow, P., Dey, S., Dey, R., Majumder, A., Nandi, S., Bera, M., & Samadder, A. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112905 · Cited by 17
Electronically powered drug delivery devices: considerations and challenges
Liu, G., Lu, Y., Zhang, F., & Liu, Q. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2141709 · Cited by 18
“Joint efforts in these devices are aimed to realize personalized medicine with intelligent and effective management of drugs [1,9].”
BackgroundCell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy
Peña, Q., Rodríguez-Calado, S., Simaan, A. J., Capdevila, M., Bayón, P., Palacios, Ò., Lorenzo, J., & Iranzo, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1060827 · Cited by 18
“To help overcome these challenges, the use of delivery systems or functional moieties that increase solubility and enhance intracellular delivery, such as viral-based vectors, vesicles, nanoparticles, or cellpenetrating peptides (CPPs) can be used (Allen and Cullis, 2004; Dhar et al., 2009; Nakase et al., 2012; Stewar…”
BackgroundNew challenges in drug discovery
Bano, I., Butt, U. D., & Mohsan, S. A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00021-5 · Cited by 17
Bioempowerment of Therapeutic Living Cells by Single‐Cell Surface Engineering
Yang, S., Choi, H., Nguyen, D. T., Kim, N., Rhee, S. Y., Han, S. Y., Lee, H., & Choi, I. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300037 · Cited by 17
Esquivel, S. V., Bhatt, H., Diwan, R., Habib, A., Lee, W., Khatun, Z., & Nurunnabi, M. (2023) · Biomolecules · doi:10.3390/biom13050768 · Cited by 19
Platelets for advanced drug delivery in cancer
Cacic, D. L., Hervig, T. A., & Reikvam, H. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2217378 · Cited by 17
“Drug delivery systems exist in many forms, including novel techniques using drug-loaded nanoparticles [95].”
BackgroundHarisa, G. I., Faris, T. M., Sherif, A. Y., Alzhrani, R. F., Alanazi, S. A., Kohaf, N. A., & Alanazi, F. K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127055 · Cited by 17
Calcium phosphates enhanced with liposomes – the future of bone regeneration and drug delivery
Skrinda-Melne, M., Ločs, J., Grava, A., & Dubņika, A. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2285973 · Cited by 17
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Wang, K., Zhou, K., Zhong, N., Cao, L., Li, Z., Xiao, Y., Wang, G.-R., Huo, F., Zhou, J., Liu, B., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122635 · Cited by 17
Muteeb, G., Khafaga, D. S. R., El-Morsy, M. T., Farhan, M., Aatif, M., & Hosney, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37217 · Cited by 17
“These enhancements have made drug delivery more selective, precise, and focused, effectively addressing challenges associated with certain treatment classes [148,149].”
BackgroundInfluentialHsu, K.-Y., Huang, S., Murti, B. T., Chen, C., Chao, Y.-C., Ha, I.-C., Tsai, C.-C., Chen, C., Tsai, M., & Yang, P. (2024) · Nano Energy · doi:10.1016/j.nanoen.2024.110501 · Cited by 17
Zhang, X., Zang, Z., Liang, Z., Xu, X., Zheng, J., Liang, N., Shabiti, S., Wang, Z., Yu, S., Wang, Y., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c16740 · Cited by 17
Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
Dai, H., Abdullah, R., Wu, X., Li, F., Ma, Y., Lü, A., & Zhang, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855474 · Cited by 17
Applications of bacteriophages in precision engineering of the human gut microbiome
Kuang, X., Shen, J., Zheng, L., Duan, Y., Ma, Y., Leung, E. L., & Dai, L. (2025) · Engineering Microbiology · doi:10.1016/j.engmic.2025.100189 · Cited by 19
“Drug delivery strategies involve three key points: 1) modification of the drug itself, 2) optimization based on the surrounding environment in which the drug is located, and 3) construction of a delivery system that controls the interaction between the drug and its microenvironment [ 137 ].”
Shape and topology morphing of closed surfaces integrating origami and kirigami
Dang, X., Chen, S., Acha, A. E., Wu, L., & Pasini, D. (2025) · Science Advances · doi:10.1126/sciadv.ads5659 · Cited by 19
“…predict the morphing of closed surfaces would enable the optimization of both structural and protective properties, benefiting a diverse range of applications involving, for example, controlled release of drugs ( 20 ), selective electromagnetic shielding ( 21 ), and responsive soft robotics ( 22 ).”
Size-dependent penetration depth of colloidal nanoparticles into cell spheroids
Zhu, D., Brückner, D., Sosniok, M., Skiba, M., Feliu, N., Gallego, M., Liu, Y., Schulz, F., Falkenberg, G., Parak, W. J., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115593 · Cited by 17
Bioelectronics for targeted pain management
Flavin, M. T., Foppiani, J., Paul, M. A., Alvarez, A. H., Foster, L., Gavlasova, D., Ma, H., Rogers, J. A., & Lin, S. J. (2025) · Nature Reviews Electrical Engineering · doi:10.1038/s44287-025-00177-3 · Cited by 18
“Microfluidic and micro-electromechanical systems enable wearable, ingestible and implantable devices that target pain with spatial and temporal precision 21,210 (Fig.”
Pulmonary inhaled drug delivery systems: From bench to bedside
He, X., Zou, J., Zhang, W., Ma, Y., & He, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114296 · Cited by 22
Crystal engineering for poorly water-soluble drugs: From design to applications
Chen, A., Peng, Y., Chen, Z., Lu, Y., Guo, M., & Cai, T. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.003 · Cited by 16
“The characterization and quality control of MOFs and drug-loaded MOFs are crucial for determining their pharmaceutical performance 206,207 .”
Pegylated Curcumin Derivative: Water-Soluble Conjugates with Antitumor and Antibacterial Activity
Yakub, G., Manolova, N. E., Rashkov, I. B., Markova, N., Toshkova, R. A., Georgieva, A. K., Mincheva, R., Toncheva, A., Raquez, J., & Dúbois, P. (2022) · ACS Omega · doi:10.1021/acsomega.2c04173 · Cited by 16
Milewska, S., Siemiaszko, G., Wilczewska, A. Z., Misztalewska‐Turkowicz, I., Markiewicz, K. H., Szymczuk, D., Sawicka, D., Car, H., Łaźny, R., & Niemirowicz-Laskowska, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021364 · Cited by 17
“This is due to minimizing off-target drug accumulation, improving the delivery of a drug to the target site, and facilitating patient compliance [13,14].”
BackgroundTay, J. H., Lim, Y. H., Zheng, M., Zhao, Y., Tan, W. S., Xu, C., Ramamurty, U., & Song, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.016 · Cited by 16
Microbial assistance in nano-carrier development: Innovative strategies in drug delivery
Pandey, T., & Pandey, V. P. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105607 · Cited by 16
Xu, Z., Lin, H., Dai, J., Wen, X., Yu, X., Xu, C., & Ruan, G. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124231 · Cited by 16
Nucleus-targeting Oxaplatin(IV) prodrug Amphiphile for enhanced chemotherapy and immunotherapy
Wei, D., Yan, J., Cao, Z., Han, S., & Sun, Y. J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.028 · Cited by 16
Lin, P., Gu, H., Zhuang, X., Wang, F., & Hu, X. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00582 · Cited by 16
Apolinário, A. C., Naser, Y. A., Volpe‐Zanutto, F., Vora, L. K., Sabri, A. H. B., Li, M., Hutton, A. R. J., McCarthy, H. O., Lopes, L. B., & Donnelly, R. F. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.080 · Cited by 16
Bashyal, S., Seo, J., Keum, T., Noh, G., Lamichhane, S., Kim, J. H., Kim, C. H., Choi, Y. W., & Lee, S. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s318092 · Cited by 16
Jash, A., Krueger, A., & Rizvi, S. S. H. (2022) · Green Chemistry · doi:10.1039/d2gc00877g · Cited by 16
Morphology‐controlled precipitation/remodeling of plate and rod‐shaped hydroxyapatite nanoparticles
Latocha, J., Wojasiński, M., Janowska, O., Chojnacka, U., Gierlotka, S., Ciach, T., & Sobieszuk, P. (2022) · AIChE Journal · doi:10.1002/aic.17897 · Cited by 16
Microneedles for anti-aging skincare: Preparation, properties and applications
Awan, K. M., Yu, H., Wang, L., Basit, A., Keshta, B. E., Wang, Y., Malik, M. O., & Uddin, M. A. (2024) · Materials Today Communications · doi:10.1016/j.mtcomm.2024.110740 · Cited by 15
Microfluidic loading of verteporfin into extracellular vesicles for neuroblastoma therapy
Piunti, C., Micheli, S., Giancaterino, S., Fusco, P., Boi, C., & Cimetta, E. (2025) · Lab on a Chip · doi:10.1039/d4lc01103a · Cited by 18
Ye, R., Ren, Q., Chang, L., Zhang, S., Deng, C., Cao, L., Shi, M., Lou, B., Meng, F., Du, S., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102741 · Cited by 16
Advancing biocompatible metal-organic frameworks in personalized biomedical applications
Yu, Z., Chivu, A., Dai, J., Patra, H. K., Zou, J., & Hu, Z. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217262 · Cited by 18
Shi, J., Li, Y., Dong, D., Li, J., Wen, T., Tang, Y., Zhang, Q., Pan, F., Yan, L., Wu, D., et al. (2025) · Molecules · doi:10.3390/molecules31010086 · Cited by 16
“The growing demand for precision medicine and personalised treatments in modern healthcare has made efficient, controllable and low-toxicity drug delivery a critical challenge in biomedical research [1–3].”
Irie, T., Das, S. C., & Negishi, Y. (2026) · Nanoscale Horizons · doi:10.1039/d5nh00612k · Cited by 16
Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics
Danielsen, M., Hempel, C., Andresen, T. L., & Urquhart, A. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.050 · Cited by 15
Whang, C., Hong, J., Kim, D., Ryu, H., Jung, W., Son, Y., Keum, H., Kim, J., Shin, H., Moon, E., et al. (2022) · Advanced Materials · doi:10.1002/adma.202203993 · Cited by 15
He, Y., Wang, J., Wang, S., Yu, K., Zhou, J., Wang, J., Tang, G., Gu, Z., & Bai, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101700 · Cited by 15
Reconstructed membrane vesicles from the microalga Dunaliella as a potential drug delivery system
Levak, M., Demir-Yilmaz, I., Formosa‐Dague, C., Vrana, I., Gašparović, B., Horvat, L. L., Butorac, A., Frkanec, R., & DeNardis, N. I. (2022) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2022.108360 · Cited by 15
“The development of drug delivery systems has been extensively researched [1 – 4].”
BackgroundLi, Y., Liang, X., Shen, C., Deng, K., Zeng, Z., Guo, B., & Xu, X. (2023) · Small · doi:10.1002/smll.202301656 · Cited by 16
Hypoxic regulation of extracellular vesicles: Implications for cancer therapy
Yoo, S., Choi, S., Kim, I., & Kim, I. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.034 · Cited by 15
Malamatari, M. (2023) · Processes · doi:10.3390/pr11102919 · Cited by 16
“The first category encompasses pharmaceutical compounds with low molecular weight, while the biologics category includes proteins and peptides, antibodies, nucleic acids, and cell therapies [3].”
BackgroundRedox modulating small molecules having antimalarial efficacy
Pal, C. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115927 · Cited by 15
Photoactivable liposomes for controlled delivery: Recent progress and design considerations
Song, S., Lee, D., Ore, L. C. D., Kwak, S., Kang, L., Kim, H. K., Malmstadt, N., Kim, S. M., & Jeon, T. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215567 · Cited by 16
Ren, L. F., Zhang, Q., Wang, W., Chen, X., Li, Z., Gong, Q., Gu, Z., & Luo, K. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.12.026 · Cited by 15
Tang, S., Gao, Y., Wang, W., Wang, Y., Liu, P., Shou, Z., Yang, R., Jin, C., Zan, X., Wang, C., et al. (2023) · ACS Macro Letters · doi:10.1021/acsmacrolett.3c00668 · Cited by 15
Kim, H. J., Cho, H. B., Kim, H.-R., Lee, S., Park, J.-I., & Park, K. (2024) · Nano Convergence · doi:10.1186/s40580-023-00409-y · Cited by 15
An artificial protein modulator reprogramming neuronal protein functions
Lin, P., Zhang, B., Yang, H., Yang, S., Xue, P., Chen, Y., Yu, S., Zhang, J., Zhang, Y., Chen, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46308-6 · Cited by 15
“…catalysts can selectively generate favorable intermediates for ef fi cient catalytic reactions 27,28 , their practical biomedical applications are hindered by inherent challenges associated with small molecules 29,30 , such as off-target side effects 31 and untargeted biodistribution 29,32 .”
Advances in Pulmonary Protein Delivery Systems
Zhao, Y., Liu, S., & Lu, X. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300176 · Cited by 17
Zhang, D., Song, Q., Wang, W., Li, Q., Zhao, Z., Jiang, Y., & Luan, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202315447 · Cited by 15
Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulation
Shang, Y., Zhu, Q., Ding, J., Zhao, L., Zhang, F., Lu, J., Feng, Y., Wang, J., Liu, Z., Kuang, M., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.048 · Cited by 15
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yang, Y., Wang, J., Zhong, Y., Tian, M., & Zhang, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c19059 · Cited by 15
Vosoughi, P., Naghib, S. M., Jafari, T., & Kangarshahi, B. M. (2025) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2025.100805 · Cited by 17
Wang, Z., Guo, Y., Li, G., Guo, H., Li, Y., Wang, J., Li, K., Mignani, S. M., Shen, M., Garanger, É., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102810 · Cited by 15
Wang, P., Liu, C., & Zheng, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102037 · Cited by 17
“” However, “ Drug delivery technologies have enabled the development of many pharmaceutical products [10].”
Barroso, N., Andreo, J., Beobide, G., Castillo, Ó., Luque, A., Pérez‐Yáñez, S., & Wuttke, S. (2023) · Communications Chemistry · doi:10.1038/s42004-022-00799-w · Cited by 16
Tariq, T., Bibi, S., Shah, S. S. A., Wattoo, M. A., Salem, M. A., El-Haroun, H., El-Bahy, Z. M., Rehman, A. U., & Bao, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106532 · Cited by 20
Metadata
- Authors
- Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Corresponding author
- Mitragotri, Samir
- Venue
- Nature Biomedical Engineering
- Published
- 2021-04-01
- Volume
- 5
- Issue
- 9
- Pages
- 951-967
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W3143156272
- Cited by
- 1,361
- References
- 275
- Citations by year
- 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
- FWCI
- 19.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (DGE-1650116)
- U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
- U.S. Department of Defense (W81XWH-19-2-0011)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
- MeSH terms
- Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review